| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0013 | 1 |